These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12139465)

  • 1. Design, synthesis, and biological evaluation of indolequinone phosphoramidate prodrugs targeted to DT-diaphorase.
    Hernick M; Flader C; Borch RF
    J Med Chem; 2002 Aug; 45(16):3540-8. PubMed ID: 12139465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of novel quinone phosphorodiamidate prodrugs targeted to DT-diaphorase.
    Flader C; Liu J; Borch RF
    J Med Chem; 2000 Aug; 43(16):3157-67. PubMed ID: 10956224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of pteroic acid-conjugated nitroheterocyclic phosphoramidates as folate receptor-targeted alkylating agents.
    Steinberg G; Borch RF
    J Med Chem; 2001 Jan; 44(1):69-73. PubMed ID: 11141089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfonyl-containing aldophosphamide analogues as novel anticancer prodrugs targeted against cyclophosphamide-resistant tumor cell lines.
    Jain M; Fan J; Baturay NZ; Kwon CH
    J Med Chem; 2004 Jul; 47(15):3843-52. PubMed ID: 15239662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and evaluation of targeted hypoxia-activated prodrugs applied to chondrosarcoma chemotherapy.
    Gerard Y; Voissière A; Peyrode C; Galmier MJ; Maubert E; Ghedira D; Tarrit S; Gaumet V; Canitrot D; Miot-Noirault E; Chezal JM; Weber V
    Bioorg Chem; 2020 May; 98():103747. PubMed ID: 32208207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of peptide conjugates of phosphoramide mustard as prodrugs activated by prostate-specific antigen.
    Wu X; Hu L
    Bioorg Med Chem; 2016 Jun; 24(12):2697-706. PubMed ID: 27156193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of cyclic and acyclic nitrobenzylphosphoramide mustards for E. coli nitroreductase activation.
    Jiang Y; Han J; Yu C; Vass SO; Searle PF; Browne P; Knox RJ; Hu L
    J Med Chem; 2006 Jul; 49(14):4333-43. PubMed ID: 16821793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological evaluation of NAD(P)H: Quinone oxidoreductase (NQO1)-targeted oridonin prodrugs possessing indolequinone moiety for hypoxia-selective activation.
    Xu S; Yao H; Pei L; Hu M; Li D; Qiu Y; Wang G; Wu L; Yao H; Zhu Z; Xu J
    Eur J Med Chem; 2017 May; 132():310-321. PubMed ID: 28395199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyloxymethyl esters of isophosphoramide mustard as new anticancer prodrugs.
    Cytarska J; Misiura K; Filip-Psurska B; Wietrzyk J
    Acta Pol Pharm; 2013; 70(3):481-7. PubMed ID: 23757939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of novel androgen-linked phosphoramide mustard prodrugs and growth-inhibitory activity in human breast cancer cells.
    Roth T; Tang W; Eisenbrand G
    Anticancer Drug Des; 1995 Dec; 10(8):655-66. PubMed ID: 8595124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phthalimide analogs of CB 1954: synthesis and bioactivation.
    Mehta LK; Hobbs S; Chen S; Knox RJ; Parrick J
    Anticancer Drugs; 1999 Sep; 10(8):777-83. PubMed ID: 10573210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
    Beall HD; Murphy AM; Siegel D; Hargreaves RH; Butler J; Ross D
    Mol Pharmacol; 1995 Sep; 48(3):499-504. PubMed ID: 7565631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldophosphamide acetal diacetate and structural analogues: synthesis and cytotoxicity studies.
    Wang YQ; Farquhar D
    J Med Chem; 1991 Jan; 34(1):197-203. PubMed ID: 1992116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INDQ/NO, a bioreductively activated nitric oxide prodrug.
    Sharma K; Iyer A; Sengupta K; Chakrapani H
    Org Lett; 2013 Jun; 15(11):2636-9. PubMed ID: 23659457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemically stable, lipophilic prodrugs of phosphoramide mustard as potential anticancer agents.
    Kwon CH; Moon KY; Baturay N; Shirota FN
    J Med Chem; 1991 Feb; 34(2):588-92. PubMed ID: 1995881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of quinazoline-phosphoramidate mustard conjugates as anticancer drugs.
    Lin S; Li Y; Zheng Y; Luo L; Sun Q; Ge Z; Cheng T; Li R
    Eur J Med Chem; 2017 Feb; 127():442-458. PubMed ID: 28092860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the mechanisms of activation of indolequinone phosphoramidate prodrugs.
    Hernick M; Borch RF
    J Med Chem; 2003 Jan; 46(1):148-54. PubMed ID: 12502368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships for DT-diaphorase reduction of hypoxic cell directed agents: indoloquinones and diaziridinyl benzoquinones.
    Bailey SM; Suggett N; Walton MI; Workman P
    Int J Radiat Oncol Biol Phys; 1992; 22(4):649-53. PubMed ID: 1544832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological studies of novel nucleoside phosphoramidate prodrugs.
    Tobias SC; Borch RF
    J Med Chem; 2001 Dec; 44(25):4475-80. PubMed ID: 11728193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.